Although CD44 and CD24 expression is a poor prognostic marker for different tumours including breast cancer,24, 30 the role of CD44 and CD24 in paclitaxel resistance of breast cancer cells stimulated by E2 needs further study. The gene discussed is CD44; the disease is breast carcinoma.